A researcher from University Hospitals Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at the 2016 San Antonio Breast Cancer Symposium. The annual symposium is ...
Dec 9, 2016
0
10
When the staff at Abington Memorial Hospital handed the breast cancer patient its new "Distress Thermometer" questionnaire, she instantly felt conflicted.
Nov 13, 2014
0
0
After having two children in her 30s, Brianna Hinojosa-Flores had been vigilant about getting mammograms and performing breast self-exams, as suggested by her gynecologist. But when she ran for a congressional seat in 2012, ...
Oct 3, 2014
0
0
They found the cancer in Colleen Duffey's liver 18 months ago, shortly after the birth of her second daughter. What they discovered next was even more chilling: It wasn't liver cancer at all; it was breast cancer that had ...
Jun 24, 2014
1
0
New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer ...
Dec 12, 2013
0
0
A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer, according to a researcher at Thomas Jefferson University's Kimmel Cancer Center.
Dec 11, 2013
0
0
When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California's Every Woman Counts (EWC) program concludes.
Sep 16, 2013
0
0
The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when ...
Jul 17, 2013
0
0
African-American women who survive breast cancer are more likely to develop heart failure than other women who have beaten the disease, according to research being presented at the American College of Cardiology's 62nd Annual ...
Mar 7, 2013
0
0
Patients with HER2-positive breast cancer being treated with anti-HER2 therapy may be able to prevent or delay resistance to the therapy with the addition of a phosphatidylinositol-3 kinase inhibitor to their treatment regimens.
Jan 23, 2013
0
0
